Hutchmed News and Activities
Presence
Headquarters: Hong Kong
CK Hutchison Holdings is one of the...
- Forbes Global 2000 (#347);
- Fortune 500 China (#118);
- Global Fortune 500 (#444);
- Hang Seng;
- TOB Iconic 10,000.
CK Hutchison Holdings is a company listed under the stock ticker 0001 (HK).
CK Hutchison Holdings has a direct presence in 8 countries.CK Hutchison Holdings has 24 subsidiaries including A.S. Watson Group, Australian Gas Infrastructure and CitiPower & Powercor Australia.
They are in:
- Utilities32%
- Telecommunications16%
- Other52%
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Hutchmed
- Johnny Cheng, Interim Chief Executive Officer and Chief Financial ...
- Ling Yang, Non-Executive Director
- Dan Eldar, Chairman of the Board
Popular executive movements at Hutchmed
- Michael Shi, Executive Vice President, Head of R&D and Chief Medical Officer, China, has left the company (posted on May 19 2026).
- Shu Kam Mok, Independent Non-Executive Director, will retire on May 12, 2026 (posted on March 9 2026).
- Tan Shao Weng has joined the company as Director (posted on October 14 2025).
Create your alert
to follow the executive moves at Hutchmed.
Pharmaceuticals
CK Hutchison Holdings has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Hutchmed
Social media about Hutchmed
- Hutchmed on Wikipedia, Google News & Yahoo Finance
- Hutchmed on LinkedIn, X (Twitter) & YouTube
